Medication info
Covalasect Tablet 80/12.5 mg (Valsartan, Hydrochlorothiazide)

Covalasect Tablet 80/12.5 mg (Valsartan, Hydrochlorothiazide)

Prescription medicationTabletOral
Ingredient · strength
Valsartan›80mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
JW Pharmaceutical Co., Ltd.
Appearance
Bright orange oval film-coated tablets
Packaging
30 tablets (10 tablets/PTP*3)
Approval status
Active

MFDS item code 200807813 · Notified 2008.07.15 · Insurance code 644912390

Summary

Main use
Treatment of essential hypertension inadequately controlled with monotherapy
Who takes it
Adults
Adult dose
○ Adults The recommended dose is 1 tablet of valsartan 80 mg/hydrochlorothiazide 12.5 mg once daily. It may be taken regardless of meals with a small amount of water. Valsartan 160 mg/hydrochlorothiazide 12.5 mg is for patients prescribed valsartan 160 mg/hydrochlorothiazide 12.5 mg for blood pressure reduction. The maximum antihypertensive effect is achieved after 2 ~ 4 weeks. ○ Patients with renal impairment No dosage adjustment is necessary in patients with mild ~ moderate renal impairment (creatinine clearance 30 mL/min or higher). ○ Patients with hepatic impairment In patients with mild ~ moderate hepatic impairment without cholestasis, do not exceed valsartan 80 mg daily.

Ingredients

Manufacturer
JW Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension inadequately controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used to effectively control blood pressure in patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy.

How to take

Adult dose

○ Adults The recommended dose is 1 tablet of valsartan 80 mg/hydrochlorothiazide 12.5 mg once daily. It may be taken regardless of meals with a small amount of water. Valsartan 160 mg/hydrochlorothiazide 12.5 mg is for patients prescribed valsartan 160 mg/hydrochlorothiazide 12.5 mg for blood pressure reduction. The maximum antihypertensive effect is achieved after 2 ~ 4 weeks. ○ Patients with renal impairment No dosage adjustment is necessary in patients with mild ~ moderate renal impairment (creatinine clearance 30 mL/min or higher). ○ Patients with hepatic impairment In patients with mild ~ moderate hepatic impairment without cholestasis, do not exceed valsartan 80 mg daily.

Precautions

This medication can cause serious harm to the fetus, especially when taken during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. It should not be used in patients who are allergic to any of its ingredients or have certain liver or kidney disorders. Patients with electrolyte imbalances such as hypokalemia, hyponatremia, or hypercalcemia, or severe renal or liver dysfunction should use this medication with caution. This medication may cause dizziness or drowsiness, so caution is required when driving or operating machinery. Potassium supplements or potassium-containing foods should not be taken without consulting a physician, and blood electrolyte levels should be monitored regularly. This medication may interact with other antihypertensive drugs, diuretics, lithium, and nonsteroidal anti-inflammatory drugs (NSAIDs), so patients must inform their doctor about any other medications they are taking. The hydrochlorothiazide component can increase sensitivity to sunlight and raise the risk of skin cancer, so sun exposure should be minimized and thorough sun protection should be practiced. Rarely, serious side effects such as angioedema, hepatitis, renal failure, hyperkalemia, hyponatremia, and shock may occur, so any abnormal symptoms should be promptly discussed with a healthcare provider. Safety and effectiveness in children have not been established, and caution is advised in the elderly based on renal function and other considerations. In case of overdose, hypotension, arrhythmias, and electrolyte abnormalities may occur, so immediate emergency treatment is required. This medication should be kept out of reach of children and stored in its original container away from moisture.

Side effects

Headache, dizziness, nasopharyngitis, fatigue, low back pain, cough, upper respiratory tract infection, diarrhea, joint pain, abdominal pain, epigastric pain, blurred vision, visual disturbances, anxiety, arthritis, bronchitis, acute bronchitis, chest pain, orthostatic dizziness, dry mouth, dyspepsia, shortness of breath, erectile dysfunction, enteritis, hyperhidrosis, sensory loss, insomnia, hypokalemia, hypotension, influenza, muscle cramps, myofascial pain, nausea, nasal congestion, nasal hemorrhage, throat pain, otitis media, limb pain, paresthesia, pharyngodynia, fever, sinus congestion, sinusitis, drowsiness, leg cramps, polyuria, palpitations, rash, ligament strain, syncope, tachycardia, tinnitus, urinary tract infection, viral infection, edema, peripheral edema, asthenia, angioedema, pruritus, serum sickness, vasculitis, hair loss, renal function impairment, myalgia, symptoms resembling anaphylaxis, hepatitis, renal failure, hyperkalemia, hyponatremia, shock, loss of consciousness, agranulocytosis, leukopenia, thrombocytopenia, aplastic anemia, hemolytic anemia, necrotizing vasculitis, toxic epidermal necrolysis, interstitial pneumonia, pulmonary edema, exacerbation of systemic lupus erythematosus, hypoglycemia, rhabdomyolysis, elevated AST, palpitations, dyspepsia, edema, weakness, hypertriglyceridemia, increased creatine kinase, decreased hemoglobin, thrombocytopenia, elevated serum potassium, hyponatremia, dizziness, vasculitis, elevated liver function tests, angioedema, rash, vesiculobullous dermatitis, renal failure, joint pain, weakness, low back pain, insomnia, decreased libido, nausea, pharyngitis, rhinitis, sinusitis, upper respiratory infection, acute respiratory distress syndrome, pneumonia, pulmonary edema, decreased serum potassium, increased serum cholesterol, increased triglycerides, hypomagnesemia, hyperuricemia, hypercalcemia, hypochloremic alkalosis, hyperglycemia, diabetes, orthostatic hypotension, cardiac arrhythmia, sensory loss, sedation, sleep disorders, depression, paresthesia, visual impairment, leukopenia, bone marrow dysfunction, acute angle-closure glaucoma, choroidal effusion, erythema multiforme, fever, acute renal failure, renal impairment, muscle cramps, weakness, acute angle-closure glaucoma, choroidal effusion, nausea, drowsiness, hypovolemia, arrhythmia, muscle rigidity

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it should be stored in a tightly closed container. The storage temperature should be kept below 30 degrees Celsius, and areas with high humidity should be avoided.

Appearance and packaging

Appearance

Bright orange oval film-coated tablets

Package unit

30 tablets (10 tablets/PTP*3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.